Abstract
Pain can be an adaptive sensation, an early warning to protect the body from tissue injury. By the introduction of hypersensitivity to normally innocuous stimuli, pain may also aid in repair after tissue damage. Pain can also be maladaptive, reflecting pathological function of the nervous system. Multiple molecular and cellular mechanisms operate alone and in combination within the peripheral and central nervous systems to produce the different forms of pain. Elucidation of these mechanisms is key to the development of treatments that specifically target underlying causes rather than just symptoms. This new approach promises to revolutionize pain diagnosis and management.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Julius, D. & Basbaum, A.I. Molecular mechanisms of nociception. Nature 413, 203–210 (2001).
Woolf, C.J. & Salter, M.W. Neuronal plasticity—increasing the gain in pain. Science 288, 1765–1768 (2000).
Sindrup, S.H. & Jensen, T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83, 389–400 (1999).
Lynch, D. in Practical Management of Pain 3rd edn. (ed. Raj, P.P.) 270–293 (Mosby, St. Louis, Missouri, 2000).
Woolf, C.J. & Mannion, R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959–1964 (1999).
Porreca, F., Ossipov, M.H. & Gebhart, G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319–325 (2002).
Boddeke, E.W. Involvement of chemokines in pain. Eur. J. Pharmacol. 429, 115–119 (2001).
Mantyh, P.W., Clohisy, D.R., Koltzenburg, M. & Hunt, S.P. Molecular mechanisms of cancer pain. Nature Rev.Cancer 2, 201–209 (2002).
Fields, H.L. Pain modulation: expectation, opioid analgesia and virtual pain. Prog. Brain Res. 122, 245–253 (2000).
Woolf, C.J. & Max, M.B. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiol. 95, 241–249 (2001).
Hunt, S.P. & Mantyh, P.W. The molecular dynamics of pain control. Nat. Rev. Neurosci. 2, 83–91 (2001).
Svensson, C.I. & Yaksh, T.L. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu. Rev. Pharmacol. Toxicol. 42, 553–583 (2002).
Burstein, R., Yarnitsky, D., Goor-Aryeh, I., Ransil, B.J. & Bajwa, Z.H. An association between migraine and cutaneous allodynia. Ann. Neurol. 47, 614–624 (2000).
Sarkar, S., Aziz, Q., Woolf, C.J., Hobson, A.R. & Thompson, D.G. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 356, 1154–1159 (2000).
Watkins, L.R., Milligan, E.D. & Maier, S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24, 450–455 (2001).
Rittner, H.L. et al. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95, 500–508 (2001).
Rose, M.A. & Kam, P.C. Gabapentin: pharmacology and its use in pain management. Anaesthesia 57, 451–462 (2002).
Goadsby, P.J., Lipton, R.B. & Ferrari, M.D. Migraine—current understanding and treatment. N. Engl. J. Med. 346, 257–270 (2002).
FitzGerald, G.A. & Patrono, C. The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. 345, 433–442 (2001).
Flores, C.M. & Mogil, J.S. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management. Pharmacogenomics 2, 177–194 (2001).
Desmeules, J.A., Oestreicher, M.K., Piguet, V., Allaz, A.F. & Dayer, P. Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan. J. Pharmacol. Exp. Ther. 288, 607–612 (1999).
Wood, J.N. II. Genetic approaches to pain therapy. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G507–G512 (2000).
Mogil, J.S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl. Acad. Sci. USA 96, 7744–7751 (1999).
Becerra, L., Breiter, H.C., Wise, R., Gonzalez, R.G. & Borsook, D. Reward circuitry activation by noxious thermal stimuli. Neuron 32, 927–946 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scholz, J., Woolf, C. Can we conquer pain?. Nat Neurosci 5 (Suppl 11), 1062–1067 (2002). https://doi.org/10.1038/nn942
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn942
This article is cited by
-
Therapeutic Potential of Combinative shRNA-Encoded Lentivirus-Mediated Gene Silencing to Accelerate Somatosensory Recovery After Spinal Cord Trauma
Neurotherapeutics (2023)
-
Progress in Pathological and Therapeutic Research of HIV-Related Neuropathic Pain
Cellular and Molecular Neurobiology (2023)
-
Desulfovibrio confers resilience to the comorbidity of pain and anxiety in a mouse model of chronic inflammatory pain
Psychopharmacology (2023)
-
Mechanisms of bone pain: Progress in research from bench to bedside
Bone Research (2022)
-
Methylene blue prevents osteoarthritis progression and relieves pain in rats via upregulation of Nrf2/PRDX1
Acta Pharmacologica Sinica (2022)